Streetbeat News

Stock Prices

XERS

Xeris Biopharma shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:34 pm

ERJ

Embraer S.A. (NYSE:ERJ) shares are trading higher after the company reported strong Q2 earnings for the 2024 fiscal year, with EPS and revenue beating analysts' estimates. The company saw significant growth in defense and security revenue and provided optimistic delivery and revenue projections for the fiscal year.

Portfolio Pulse from Dylan Berman

August 08, 2024 | 4:31 pm

FCNCA

First Citizens BancShares (NASDAQ:FCNCA) has significantly outperformed the market over the past 15 years, delivering an average annual return of 18.66%. A $1000 investment in FCNCA 15 years ago would be worth $12,656.45 today. The company's current market capitalization is $28.50 billion.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:30 pm

BRO

Brown & Brown (NYSE:BRO) has outperformed the market over the past 5 years with an annualized return of 22.31%, significantly higher than the market average. A $100 investment in BRO 5 years ago would now be worth $276.04. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:30 pm

ECPG

Encore Capital shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:30 pm

ALDX

Aldeyra Therapeutics Inc. (NASDAQ: ALDX) announced that its Phase 3 clinical trial for the dry eye drug reproxalap met its primary endpoint, showing significant improvement in ocular discomfort. The study's success has led to a 34.8% increase in ALDX stock price. The company plans to resubmit its New Drug Application (NDA) to the FDA in 2024, with a review period expected to last six months.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 4:30 pm

UONE

Urban One shares are trading higher following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:28 pm

AMPY

Amplify Energy shares are trading higher after the company reported better-than-expected sales results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:27 pm

DHX

DHI Group shares are trading higher following the company's announcement of better-than-expected Q2 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 4:26 pm

BROS

Dutch Bros Inc. (NYSE:BROS) shares are falling after the company reported its second-quarter results. Despite beating analyst expectations on the top and bottom lines, the company issued full-year revenue guidance below the consensus estimate. Analysts have adjusted their price targets, with Baird lowering from $42 to $37 and TD Cowen from $50 to $47. The stock is down 20.6% at $29.92, trading well below its 50-day moving average of $38.98.

Portfolio Pulse from Erica Kollmann

August 08, 2024 | 4:25 pm